CGON
Price
$21.53
Change
+$0.80 (+3.86%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
1.64B
13 days until earnings call
MRUS
Price
$44.37
Change
+$2.54 (+6.07%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
3.06B
18 days until earnings call
Ad is loading...

CGON vs MRUS

Header iconCGON vs MRUS Comparison
Open Charts CGON vs MRUSBanner chart's image
CG Oncology
Price$21.53
Change+$0.80 (+3.86%)
Volume$31.09K
Capitalization1.64B
Merus
Price$44.37
Change+$2.54 (+6.07%)
Volume$10.76K
Capitalization3.06B
CGON vs MRUS Comparison Chart
Loading...
CGON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CGON vs. MRUS commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGON is a Hold and MRUS is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (CGON: $20.73 vs. MRUS: $41.78)
Brand notoriety: CGON and MRUS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGON: 90% vs. MRUS: 216%
Market capitalization -- CGON: $1.56B vs. MRUS: $2.89B
CGON [@Biotechnology] is valued at $1.56B. MRUS’s [@Biotechnology] market capitalization is $2.89B. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGON’s FA Score shows that 0 FA rating(s) are green whileMRUS’s FA Score has 1 green FA rating(s).

  • CGON’s FA Score: 0 green, 5 red.
  • MRUS’s FA Score: 1 green, 4 red.
According to our system of comparison, MRUS is a better buy in the long-term than CGON.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGON’s TA Score shows that 5 TA indicator(s) are bullish while MRUS’s TA Score has 5 bullish TA indicator(s).

  • CGON’s TA Score: 5 bullish, 4 bearish.
  • MRUS’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, CGON is a better buy in the short-term than MRUS.

Price Growth

CGON (@Biotechnology) experienced а +2.52% price change this week, while MRUS (@Biotechnology) price change was -0.31% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.94%. For the same industry, the average monthly price growth was -5.37%, and the average quarterly price growth was -12.15%.

Reported Earning Dates

CGON is expected to report earnings on May 08, 2025.

MRUS is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+7.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MRUS($3.07B) has a higher market cap than CGON($1.64B). MRUS YTD gains are higher at: 5.493 vs. CGON (-27.720). CGON has higher annual earnings (EBITDA): -95.94M vs. MRUS (-269.6M). CGON (541M) and MRUS (537M) have equal amount of cash in the bank . CGON has less debt than MRUS: CGON (296K) vs MRUS (9.91M). MRUS has higher revenues than CGON: MRUS (36.1M) vs CGON (684K).
CGONMRUSCGON / MRUS
Capitalization1.64B3.07B54%
EBITDA-95.94M-269.6M36%
Gain YTD-27.7205.493-505%
P/E RatioN/AN/A-
Revenue684K36.1M2%
Total Cash541M537M101%
Total Debt296K9.91M3%
FUNDAMENTALS RATINGS
MRUS: Fundamental Ratings
MRUS
OUTLOOK RATING
1..100
4
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
PROFIT vs RISK RATING
1..100
32
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
57
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CGONMRUS
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
81%
Momentum
ODDS (%)
Bullish Trend 2 days ago
57%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 4 days ago
84%
Declines
ODDS (%)
Bearish Trend 17 days ago
88%
Bearish Trend 2 days ago
79%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
63%
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
73%
View a ticker or compare two or three
Ad is loading...
CGON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RERCX54.010.63
+1.18%
American Funds Europacific Growth R3
LICQX15.52N/A
N/A
Lord Abbett International Equity R2
ABSAX18.79N/A
N/A
American Beacon Small Cp Val A
IENRX8.80N/A
N/A
Macquarie Climate Solutions R6
LMCCX27.56N/A
N/A
Lord Abbett Mid Cap Stock C

CGON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGON has been loosely correlated with SYRE. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if CGON jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGON
1D Price
Change %
CGON100%
+1.22%
SYRE - CGON
53%
Loosely correlated
+1.86%
ACLX - CGON
50%
Loosely correlated
+0.81%
IDYA - CGON
50%
Loosely correlated
+0.91%
NUVL - CGON
49%
Loosely correlated
+1.85%
BHVN - CGON
49%
Loosely correlated
+1.28%
More

MRUS and

Correlation & Price change

A.I.dvisor indicates that over the last year, MRUS has been loosely correlated with CGON. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if MRUS jumps, then CGON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRUS
1D Price
Change %
MRUS100%
+6.05%
CGON - MRUS
45%
Loosely correlated
+3.81%
ACLX - MRUS
43%
Loosely correlated
+0.53%
RCKT - MRUS
41%
Loosely correlated
+4.06%
KRYS - MRUS
40%
Loosely correlated
+2.00%
XENE - MRUS
39%
Loosely correlated
+1.62%
More